Skip to content

Rivaroxaban

Its Direct factor Xa inhibitor classification provides context for the Blood Thinners treatment area. Readers can review the stated strength, presentation and ingredient details together in one focused catalogue view.

Xarelto

Prevention of Atherothrombotic Events in Adult Patients After An Acute Coronary Syndrome with Elevated Cardiac Biomarkers, Co-administered with Acetylsalicylic Acid Alone or with Clopidogrel or Ticlopidine

15mg

Directly inhibits factor Xa to interrupt both intrinsic and extrinsic coagulation pathways, reducing thrombin generation and preventing formation and extension of blood clots.

From$2.98/ tabletView

Where does Rivaroxaban fit in treatment?

Related medicines appear within Blood Thinners.

Important safety information for Rivaroxaban

Information about Rivaroxaban on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.